Home » Boston Scientific’s Drug-Eluting Stent Receives FDA Approval
Boston Scientific’s Drug-Eluting Stent Receives FDA Approval
The FDA approved Boston Scientific’s premarket approval application for its Eluvia drug-eluting vascular stent system.
The device is developed to treat peripheral artery disease by using a drug-polymer combination to continually release paclitaxel over one year.
It is designed to stop tissue from regrowing that may become an obstruction for the stented artery.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May